Literature DB >> 19153346

Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure.

Majed Eshki1, Laurence Allanore, Philippe Musette, Brigitte Milpied, Anne Grange, Jean-Claude Guillaume, Olivier Chosidow, Isabelle Guillot, Valérie Paradis, Pascal Joly, Béatrice Crickx, Sylvie Ranger-Rogez, Vincent Descamps.   

Abstract

BACKGROUND: Factors implicated in the severity of drug reaction with eosinophilia and systemic symptoms (DRESS) have not been identified. We retrospectively describe and analyze severe cases of DRESS defined by history of intensive care unit admission and death due to DRESS. OBSERVATIONS: Of 15 patients retrospectively recruited in France, 14 were admitted to the intensive care unit and 3 died. The culprit drugs were already known to cause or trigger DRESS: allopurinol, minocycline hydrochloride, anticonvulsants, sulfonamides, and antibiotics. Visceral involvement with severe manifestations responsible for intensive care unit admission or death was variable and often multiple (pneumonitis, hepatitis, renal failure, encephalitis, hemophagocytosis, cardiac failure, and pancytopenia) and resulted in multiorgan failure in 11 patients. These severe complications sometimes developed late in DRESS. Human herpesvirus 6 infection was demonstrated in 6 of 7 patients. In addition, human herpesvirus 6 infection was demonstrated in involved viscera in 2 patients.
CONCLUSIONS: Severe DRESS is rare. Some specificities of visceral involvement were associated with allopurinol and minocycline. However, visceral involvement comprising multiorgan failure seemed to be unpredictable. Better knowledge of DRESS is necessary to propose specific and prompt treatment. Early demonstration of human herpesvirus 6 reactivation could be considered a prognostic factor for identifying patients at higher risk and, hence, needs to be evaluated.

Entities:  

Mesh:

Year:  2009        PMID: 19153346     DOI: 10.1001/archderm.145.1.67

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  53 in total

1.  Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome.

Authors:  J Ahluwalia; K Abuabara; M J Perman; A C Yan
Journal:  Br J Dermatol       Date:  2015-02-27       Impact factor: 9.302

2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

3.  A 63-year-old returned traveller with fever, rash, hepatitis and eosinophilia.

Authors:  Samira Jeimy; Kathryn McRae; Reena Pattani
Journal:  CMAJ       Date:  2018-07-09       Impact factor: 8.262

4.  Cutaneous side effects of antiosteoporosis treatments.

Authors:  Philippe Musette; Jean-Marc Kaufman; René Rizzoli; Patrice Cacoub; Maria Louisa Brandi; Jean-Yves Reginster
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-02       Impact factor: 5.346

Review 5.  Drug Hypersensitivity.

Authors:  Ruwen Böhm; Ehrhardt Proksch; Thomas Schwarz; Ingolf Cascorbi
Journal:  Dtsch Arztebl Int       Date:  2018-07-23       Impact factor: 5.594

6.  Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.

Authors:  Muhammad Riaz; Bruce D Ragsdale; Zia Ur Rahman; Gaurav Nigam
Journal:  BMJ Case Rep       Date:  2017-08-22

7.  Markers of systemic involvement and death in hospitalized cancer patients with severe cutaneous adverse reactions.

Authors:  Shoko Mori; Alanna Hickey; Stephen W Dusza; Mario E Lacouture; Alina Markova
Journal:  J Am Acad Dermatol       Date:  2018-10-26       Impact factor: 11.527

8.  Two cases with HSS/DRESS syndrome developing after prosthetic joint surgery: does vancomycin-laden bone cement play a role in this syndrome?

Authors:  Müberra Devrim Güner; Semra Tuncbilek; Burak Akan; Aysun Caliskan-Kartal
Journal:  BMJ Case Rep       Date:  2015-05-28

Review 9.  Recent advances in the understanding of severe cutaneous adverse reactions.

Authors:  N R Adler; A K Aung; E N Ergen; J Trubiano; M S Y Goh; E J Phillips
Journal:  Br J Dermatol       Date:  2017-09-29       Impact factor: 9.302

10.  Testing for drug hypersensitivity syndromes.

Authors:  Craig M Rive; Jack Bourke; Elizabeth J Phillips
Journal:  Clin Biochem Rev       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.